Mesoblast rattles tin for at least $37m with Bell Potter

MELBOURNE: Mesoblast, the local biotech developing treatments for cardiovascular disease and back pain, ... read more

Brookfield set to buy back debt in Healthscope deal

MELBOURNE: Canadian private equity fund Brookfield is understood to have bought back about ... read more

Morgan Stanley tapping Rothschild for Healius group bid

MELBOURNE: Morgan Stanley Infrastructure Partners is understood to have tapped advisory firm Rothschild ... read more

JPMorgan now lined up for Ramsay sell-off

SYDNEY: Investment bank JPMorgan is believed to be in the box seat to ... read more